» Articles » PMID: 18033316

Involvement of Mature Donor T Cells in the NK Cell Reconstitution After Haploidentical Hematopoietic Stem-cell Transplantation

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2007 Nov 23
PMID 18033316
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We previously demonstrated that natural killer (NK) cells generated after haploidentical stem-cell transplantation (SCT) are blocked at an immature state characterized by phenotypic features and impaired functioning and that this may affect transplantation outcome. We hypothesize that the absence of mature donor T cells in the graft may affect NK cell differentiation. NK cells from 21 transplant recipients who underwent either partial (pTCD; n=11) or extensive (eTCD; n=10) T-cell depletion were compared with NK cells from their healthy donors. We report that despite the strong graft-versus-host disease (GvHD) reaction, pTCD patients, with T cells present during SCT, had a better clinical outcome than patients with eTCD transplants. In addition, the frequency of CD3- CD56(bright) and NKG2A+ NK cells was much lower in pTCD than in eTCD patients after transplantation, and the level of cytotoxicity against primary haplo-mismatched blasts was significantly more pronounced after pTCD than eTCD transplants. These finding strongly suggest that mature donor T cells in the graft may play a key role in NK cell differentiation in vivo, after haploidentical SCT.

Citing Articles

Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin: a prospective cohort study.

Kerbauy M, Rocha F, Arcuri L, Cunegundes P, Kerbauy L, Machado C Haematologica. 2024; 110(3):640-650.

PMID: 39279428 PMC: 11873711. DOI: 10.3324/haematol.2024.285921.


Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.

van der Ploeg K, Sottile R, Kontopoulos T, Shaffer B, Papanicolaou G, Maloy M Blood Adv. 2023; 7(19):5784-5798.

PMID: 37196646 PMC: 10561005. DOI: 10.1182/bloodadvances.2022008952.


Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.

Mushtaq M, Shahzad M, Shah A, Chaudhary S, Zafar M, Anwar I Front Immunol. 2022; 13:1005031.

PMID: 36263054 PMC: 9574024. DOI: 10.3389/fimmu.2022.1005031.


Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?.

Damele L, Spaggiari G, Parodi M, Mingari M, Vitale M, Vitale C Cancers (Basel). 2022; 14(18).

PMID: 36139598 PMC: 9496735. DOI: 10.3390/cancers14184439.


Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer.

Zhao X, Cai L, Hu Y, Wang H Front Immunol. 2020; 11:584099.

PMID: 33193399 PMC: 7642255. DOI: 10.3389/fimmu.2020.584099.